DECN
Decision Diagnostics Corp
Price:  
0.00 
USD
Volume:  
44,330.00
United States | Health Care Technology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DECN WACC - Weighted Average Cost of Capital

The WACC of Decision Diagnostics Corp (DECN) is 5.2%.

The Cost of Equity of Decision Diagnostics Corp (DECN) is 1,421.90%.
The Cost of Debt of Decision Diagnostics Corp (DECN) is 5.00%.

Range Selected
Cost of equity 5.20% - 2,838.60% 1,421.90%
Tax rate -% - -% -%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.0% - 5.3% 5.2%
WACC

DECN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta -601.57 11.65
Additional risk adjustments 2768.5% 2769.0%
Cost of equity 5.20% 2,838.60%
Tax rate -% -%
Debt/Equity ratio 8263.7 8263.7
Cost of debt 5.00% 5.00%
After-tax WACC 5.0% 5.3%
Selected WACC 5.2%

DECN's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for DECN:

cost_of_equity (1,421.90%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (-601.57) + risk_adjustments (2,768.75%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.